Bulletin
Investor Alert

New York Markets Open in:

Jasper Therapeutics Inc.

NAS: JSPR

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 15, 2022, 5:15 p.m.

/zigman2/quotes/206872721/composite

$

2.25

Change

+0.15 +7.14%

Volume

Volume 2,531

Quotes are delayed by 20 min

/zigman2/quotes/206872721/composite

Previous close

$ 2.26

$ 2.10

Change

-0.16 -7.08%

Day low

Day high

$2.10

$2.41

Open

52 week low

52 week high

$1.73

$18.88

Open

Insider Actions for Jasper Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/27/2022 William Lis
Director
24,743   Disposition at $2.08 per share. 51,465
06/24/2022 William Lis
Director
24,743   Disposition at $2.02 per share. 49,980
03/21/2022 William Lis
Director
89,972   Award at $0 per share. 0
09/24/2021 Metalmark Capital LLC
2,300,000   Derivative/Non-derivative trans. at $0 per share. 0
09/24/2021 Metalmark Capital LLC
2,300,000   Derivative/Non-derivative trans. at $0 per share. 0
09/24/2021 Metalmark Capital LLC
2,300,000   Derivative/Non-derivative trans. at $0 per share. 0
09/24/2021 Metalmark Capital LLC
2,300,000   Derivative/Non-derivative trans. at $0 per share. 0
04/23/2021 Glazer Capital LLC
151,719   Disposition at $9.92 per share. 1,505,052
04/21/2021 Glazer Capital LLC
1,164   Disposition at $9.92 per share. 11,546
04/19/2021 Glazer Capital LLC
2,060   Disposition at $9.97 per share. 20,538
02/22/2021 Glazer Capital LLC
698   Disposition at $10.5 per share. 7,329
02/19/2021 Glazer Capital LLC
2,112   Disposition at $10.5 per share. 22,176
02/18/2021 Glazer Capital LLC
10,000   Disposition at $10.45 per share. 104,500

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
2 Sales
0
49,486
Last 6 months
1 Purchases
2 Sales
89,972
49,486
Last 12 months
5 Purchases
2 Sales
9,289,972
49,486

Officers and Executives

Mr. William Lis
Non-Executive Chairman
Mr. Ronald A. Martell
President, Chief Executive Officer & Director
Mr. Jeet Mahal
Chief Operating & Financial Officer
Dr. Wendy Pang
Senior VP-Research & Translational Medicine
Dr. Luca Di Noto
Vice President-Technical Operations
Mr. Jason Carlton
Vice President-Clinical Operations
Dr. Judith Shizuru
Director
Mr. Arjun Agarwal
Vice President-Finance & Controller
Dr. Carol Zoltowski
Senior Vice President-Regulatory Affairs & Quality
Mr. Konrad Hans von Emster
Independent Director
Dr. Anna French
Independent Director
Mr. Christian W. Nolet
Independent Director
Dr. Lawrence O. Klein
Independent Director
Link to MarketWatch's Slice.